Cardiology - European Medical Journal

This site is intended for healthcare professionals

Continue

Cardiology

Filter
EMJ
12 Oct 2015

Heartening Protein Patch Developed to Repair Cardiomyocyte Damage

A REVOLUTIONARY ‘protein patch’ has been developed that repairs the damage caused by a heart attack. Investigating a treatment to address the inability…
EMJ
12 Oct 2015

Catheter Ablation Versus Drug Therapy: The Atrial Fibrillation Showdown

EVIDENCE that catheter ablation is superior to drug therapy for reducing atrial fibrillation (AF) has been newly presented. A recent trial investigating…
EMJ
2 Sep 2015

CardioSecur: 22-Lead Mobile ECG Enables 360-Degree View of the Heart

London (28.08.2015). Personal MedSystems introduces the first and only 22-lead mobile ECG system, CardioSecur, at the European Society of Cardiology…
EMJ
1 Sep 2015

Siemens Solutions Support Diagnosis and Treatment of Cardiovascular Diseases

Cardiovascular diseases such as heart attack, stroke, and coronary heart disease have been among the most common causes of death worldwide for many years…
EMJ
23 Jul 2015

ESC Congress 2015 Hot Lines to Reveal the Latest in CVD Research

Sophia Antipolis, 23 July 2015 – Six hot line sessions at ESC Congress 2015 are set to reveal the latest in cardiovascular disease research across a…
EMJ
24 Jun 2015

First ESC Recommendations for Arrhythmias and Chronic Kidney Disease Published

Milan, Italy – 24 June 2015: The first ESC recommendations for patients with cardiac arrhythmias and chronic kidney disease (CKD) are presented today…
EMJ
24 Jun 2015

Uninterrupted NOAC Therapy during AF Ablation Is Safe

Milan, Italy – 24 June 2015: Uninterrupted treatment with novel oral anticoagulants (NOACs) during catheter ablation of atrial fibrillation (AF) is safe…
EMJ
24 Jun 2015

ESC Recommends Uninterrupted Vitamin K Antagonists during Ablation and Device Implantation

Milan, Italy – 23 June 2015: The European Society of Cardiology (ESC) has recommended uninterrupted anticoagulation with vitamin K antagonists…
We’ve noticed you’re accessing
from North/South America.